+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hong Kong Wound Care Market Research Report: By Type, Application, End User, Distribution Channel - Industry Analysis and Growth Forecast to 2030

  • ID: 5184630
  • Report
  • August 2020
  • Region: Hong Kong
  • 197 pages
  • Prescient & Strategic Intelligence Private Limited

FEATURED COMPANIES

  • 3M Company
  • BSN medical GmbH
  • ConvaTec Group PLC
  • Medtronic plc
  • Paul Hartmann AG
  • Wayson Medical Co. Ltd.
  • MORE
As per a report by the publisher, the Hong Kong wound dressing market reached a value of $38.9 million, and is projected to exhibit a CAGR of 5.9% during the forecast period (2020–2030). The major factors leading to the growth of the market are rising prevalence of diabetes, increasing incidence of traumatic injuries, and growing geriatric population. On the basis of type, the market is divided into traditional and advanced, between which, the advanced category dominated the market in 2019.

Advanced wound dressing is highly advantageous for traumatic injuries that are severe and need prompt medical attention to reduce the patient’s susceptibility to infections. Moreover, this dressing type regulate the moisture level and absorb exudate around the wound, and hence protects the wound base and the tissue around it. The advanced division is further categorized into films, foams, hydrocolloids, alginates, superabsorbents, hydrogels, wound contact layers, collagen, hydrofiber, and negative pressure wound therapy, among which, foam held the largest share of the market in 2019.

The shifting preference from traditional wound dressings to advanced variants is a major trend in the Hong Kong wound dressing market. Traditional dressing products serve as secondary dressing products for holding the primary dressing in place or facilitate dry healing. Advanced wound dressing, however, accelerates the healing process and provided quick relief to patients. It is because of such advantages of advanced wound dressing that the healthcare professionals are adopting them. While the demand for traditional products has decreased, the outlook towards advanced variants is changing for the good in Hong Kong.

A major factor leading to the growth of the Hong Kong wound dressing market is the rapidly rising prevalence of diabetes in the country. Diabetes can often lead to diabetic foot ulcer, which is a chronic complication of diabetes mellitus. In order to manage this disease frequent dressings are required. Hence, as the number of people suffering from diabetes will rise in Hong Kong, the need for wound dressing will grow as well.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Company
  • BSN medical GmbH
  • ConvaTec Group PLC
  • Medtronic plc
  • Paul Hartmann AG
  • Wayson Medical Co. Ltd.
  • MORE
Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Type
1.3.2 Market Segmentation by Application
1.3.3 Market Segmentation by End User
1.3.4 Market Segmentation by Distribution Channel
1.3.5 Analysis Period
1.3.6 Market Data Reporting Unit
1.4 Key Stakeholders

Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown of Primary Research Respondents
2.2.1.1 By industry participant
2.2.1.2 By company type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction
4.1 Market Definition
4.1.1 By Type
4.1.1.1 Advanced
4.1.1.1.1 Wound dressings
4.1.1.1.1.1 Foam
4.1.1.1.1.2 Hydrocolloid
4.1.1.1.1.3 Film
4.1.1.1.1.4 Alginate
4.1.1.1.1.5 Antimicrobial
4.1.1.1.1.6 Hydrogel
4.1.1.1.1.7 Collagen
4.1.1.1.1.8 Hydrofiber
4.1.1.1.1.9 Wound contact layer
4.1.1.1.1.10 Superabsorbent
4.1.1.1.1.11 Others
4.1.1.1.2 Wound therapy devices
4.1.1.1.2.1 NPWT devices
4.1.1.1.2.2 Pressure relief devices
4.1.1.1.2.3 Others
4.1.1.1.3 Wound care biologics
4.1.1.1.3.1 Skin substitutes
4.1.1.1.3.2 Collagen-based
4.1.1.1.3.3 Growth factors
4.1.1.1.3.4 Others
4.1.1.2 Traditional
4.1.1.2.1 Bandages
4.1.1.2.2 Fixation tapes
4.1.1.2.3 Gauzes
4.1.1.2.4 Sponges
4.1.1.2.5 Abdominal pads
4.1.1.2.6 Others
4.1.2 By Application
4.1.2.1 Chronic wounds
4.1.2.1.1 DFUs
4.1.2.1.2 Pressure ulcers
4.1.2.1.3 VLUs
4.1.2.1.4 Others
4.1.2.2 Acute wounds
4.1.2.2.1 Surgical and traumatic wounds
4.1.2.2.2 Burns
4.1.2.2.3 Others
4.1.3 By End User
4.1.3.1 Hospitals and specialty clinics
4.1.3.1.1 Inpatient settings
4.1.3.1.2 Outpatient settings
4.1.3.2 Home healthcare
4.1.3.3 Long-term care settings
4.1.4 By Distribution Channel
4.1.4.1 Pharmacies
4.1.4.2 Online channels
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Shift in preference from traditional products to advanced therapies
4.2.2 Drivers
4.2.2.1 Growing geriatric population
4.2.2.2 Increasing prevalence of diabetes
4.2.2.3 High incidence of traumatic injuries
4.2.2.4 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 High cost of advanced wound care products
4.2.3.2 Impact analysis of restraints on market forecast
4.2.4 Opportunities
4.2.4.1 Improving economy and increasing health expenditure
4.2.4.2 Ineffectiveness of traditional wound dressings in acute wound management
4.3 Impact of COVID-19
4.4 Porter’s Five Forces Analysis
4.5 Regulatory Overview
4.6 Wound Dressing Product Pricing
4.7 Healthcare Insurance Scenario in Hong Kong

Chapter 5. Epidemiology of Wounds in Hong Kong
5.1 Total Incidence of Wounds
5.2 Type-Specific Incidence of Wounds
5.2.1 Incident Cases of Acute Wounds, by Subtype
5.2.2 Incident Cases of Chronic Wounds, by Subtype

Chapter 6. Hong Kong Market Size and Forecast
6.1 By Type
6.1.1 Advanced Wound Care Market, by Type
6.1.1.1 Advanced wound dressing market, by type
6.1.1.1.1 Foam dressing market
6.1.1.1.1.1 By hospital type
6.1.1.1.1.2 By prescription mode
6.1.1.1.2 Hydrocolloid dressing market
6.1.1.1.2.1 By hospital type
6.1.1.1.2.2 By prescription mode
6.1.1.1.3 Film dressing market
6.1.1.1.3.1 By hospital type
6.1.1.1.3.2 By prescription mode
6.1.1.1.4 Alginate dressing market
6.1.1.1.4.1 By hospital type
6.1.1.1.4.2 By prescription mode
6.1.1.1.5 Antimicrobial dressing market
6.1.1.1.5.1 By hospital type
6.1.1.1.5.2 By prescription mode
6.1.1.1.6 Hydrogel dressing market
6.1.1.1.6.1 By hospital type
6.1.1.1.6.2 By prescription mode
6.1.1.1.7 Collagen dressing market
6.1.1.1.7.1 By hospital type
6.1.1.1.7.2 By prescription mode
6.1.1.1.8 Hydrofiber dressing market
6.1.1.1.8.1 By hospital type
6.1.1.1.8.2 By prescription mode
6.1.1.1.9 Wound contact layer dressing market
6.1.1.1.9.1 By hospital type
6.1.1.1.9.2 By prescription mode
6.1.1.1.10 Superabsorbent dressing market
6.1.1.1.10.1 By hospital type
6.1.1.1.10.2 By prescription mode
6.1.1.2 Wound care biologics market, by type
6.1.1.2.1 Skin substitutes market, by type
6.1.1.3 Wound therapy devices market, by type
6.1.2 Traditional Wound Dressing Market, by Type
6.2 By Application
6.2.1 Wound Dressing Market for Chronic Wounds, by Type
6.2.2 Wound Dressing Market for Acute Wounds, by Type
6.3 By End User
6.3.1 Wound Dressing Market in Hospitals and Specialty Clinics, by Type
6.4 By Distribution Channel

Chapter 7. Competitive Landscape
7.1 Company Benchmarking Based on Product Offerings
7.2 Revenue Share Analysis of Major Companies
7.2.1 3M Company
7.2.2 ConvaTec Group Plc
7.2.3 Coloplast A/S
7.2.4 PAUL HARTMANN Asia-Pacific Ltd.
7.2.5 Winner Medical Co. Ltd.
7.2.6 Mölnlycke Health Care AB
7.2.7 Smith & Nephew plc
7.3 Advanced Wound Dressing Usage Share Analysis, by Hospital
7.3.1 Government Hospitals
7.3.1.1 Tuen Mun Hospital (TMH)
7.3.1.2 United Christian Hospital (UCH)
7.3.1.3 Queen Elizabeth Hospital (QEH)
7.3.1.4 Prince of Wales Hospital (PWH)
7.3.1.5 Pamela Youde Nethersole Eastern Hospital (PYNEH)
7.3.1.6 Princess Margaret Hospital (PMH)
7.3.1.7 Queen Mary Hospital (QMH)
7.3.2 Private Hospitals
7.3.2.1 Evangel Hospital
7.3.2.2 Gleneagles Hong Kong Hospital
7.3.2.3 Hong Kong Adventist Hospital
7.3.2.4 Hong Kong Baptist Hospital
7.3.2.5 Hong Kong Sanatorium & Hospital Limited
7.3.2.6 Matilda & War Memorial Hospital
7.3.2.7 Precious Blood Hospital
7.3.2.8 St. Paul's Hospital
7.3.2.9 St. Teresa's Hospital
7.3.2.10 Union Hospital
7.3.2.11 Canossa Hospital
7.4 Strategic Developments of Key Players
7.4.1 Mergers and Acquisitions
7.4.2 Partnerships
7.4.3 Other Developments

Chapter 8. Company Profiles
8.1 Coloplast A/S
8.1.1 Business Overview
8.1.2 Product and Service Offerings
8.1.3 Key Financial Summary
8.2 3M Company
8.2.1 Business Overview
8.2.2 Product and Service Offerings
8.2.3 Key Financial Summary
8.3 Paul Hartmann AG
8.3.1 Business Overview
8.3.2 Product and Service Offerings
8.3.3 Key Financial Summary
8.4 Winner Medical Co. Ltd.
8.4.1 Business Overview
8.4.2 Product and Service Offerings
8.5 Mölnlycke Health Care AB
8.5.1 Business Overview
8.5.2 Product and Service Offerings
8.5.3 Key Financial Summary
8.6 Smith & Nephew plc
8.6.1 Business Overview
8.6.2 Product and Service Offerings
8.6.3 Key Financial Summary
8.7 ConvaTec Group PLC
8.7.1 Business Overview
8.7.2 Product and Service Offerings
8.7.3 Key Financial Summary
8.8 Allmed Medical Products Co. Ltd.
8.8.1 Business Overview
8.8.2 Product and Service Offerings
8.9 Zhende Medical Co. Ltd.
8.9.1 Business Overview
8.9.2 Product and Service Offerings
8.10 Wayson Medical Co. Ltd.
8.10.1 Business Overview
8.10.2 Product and Service Offerings
8.11 B. Braun Melsungen AG
8.11.1 Business Overview
8.11.2 Product and Service Offerings
8.11.3 Key Financial Summary
8.12 BSN medical GmbH
8.12.1 Business Overview
8.12.2 Product and Service Offerings
8.13 Beiersdorf AG
8.13.1 Business Overview
8.13.2 Product and Service Offerings
8.13.3 Key Financial Summary
8.14 Johnson & Johnson
8.14.1 Business Overview
8.14.2 Product and Service Offerings
8.14.3 Key Financial Summary
8.15 Urgo Medical
8.15.1 Business Overview
8.15.2 Product and Service Offerings
8.16 Cardinal Health Inc.
8.16.1 Business Overview
8.16.2 Product and Service Offerings
8.16.3 Key Financial Summary
8.17 Medtronic plc
8.17.1 Business Overview
8.17.2 Product and Service Offerings
8.17.3 Key Financial Summary
8.18 Integra LifeSciences Holdings Corporation
8.18.1 Business Overview
8.18.2 Product and Service Offerings
8.18.3 Key Financial Summary
8.19 Wright Medical Group N.V.
8.19.1 Business Overview
8.19.2 Product and Service Offerings
8.19.3 Key Financial Summary
8.20 Medela Healthcare
8.20.1 Business Overview
8.20.2 Product and Service Offerings
8.21 Lohmann & Rauscher GmbH & Co. KG
8.21.1 Business Overview
8.21.2 Product and Service Offerings
8.22 Nitto Denko Corporation
8.22.1 Business Overview
8.22.2 Product and Service Offerings
8.22.3 Key Financial Summary
8.23 Weigao Group Co. Ltd.
8.23.1 Business Overview
8.23.2 Product and Service Offerings
8.23.3 Key Financial Summary

Chapter 9. Appendix
9.1 Abbreviations
9.2 Sources and References
9.3 Related Report

List of Tables
TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 4 PRICING OF SOME MAJORLY USED WOUND DRESSING PRODUCTS
TABLE 5 TOTAL INCIDENCE OF WOUNDS IN HONG KONG (2014-2019)
TABLE 6 TOTAL INCIDENCE OF WOUNDS IN HONG KONG (2020-2030)
TABLE 7 TYPE-SPECIFIC INCIDENCE OF WOUNDS IN HONG KONG (2014-2019)
TABLE 8 TYPE-SPECIFIC INCIDENCE OF WOUNDS IN HONG KONG (2020-2030)
TABLE 9 INCIDENT CASES OF ACUTE WOUNDS, BY SYBTYPE IN HONG KONG (2014-2019)
TABLE 10 INCIDENT CASES OF ACUTE WOUNDS, BY SYBTYPE IN HONG KONG (2020-2030)
TABLE 11 INCIDENT CASES OF CHRONIC WOUNDS, BY SYBTYPE IN HONG KONG (2014-2019)
TABLE 12 INCIDENT CASES OF CHRONIC WOUNDS, BY SYBTYPE IN HONG KONG (2020-2030)
TABLE 13 HONG KONG WOUND CARE MARKET, BY TYPE, $’000 (2014-2019)
TABLE 14 HONG KONG WOUND CARE MARKET, BY TYPE, $’000 (2020-2030)
TABLE 15 HONG KONG ADVANCED WOUND CARE MARKET, BY TYPE, $’000 (2014-2019)
TABLE 16 HONG KONG ADVANCED WOUND CARE MARKET, BY TYPE, $’000 (2020-2030)
TABLE 17 HONG KONG ADVANCED WOUND DRESSING MARKET, BY TYPE, $’000 (2014-2019)
TABLE 18 HONG KONG ADVANCED WOUND DRESSING MARKET, BY TYPE, $’000 (2020-2030)
TABLE 19 HONG KONG ADVANCED WOUND DRESSING MARKET, BY TYPE, UNITS (2014-2019)
TABLE 20 HONG KONG ADVANCED WOUND DRESSING MARKET, BY TYPE, UNITS (2020-2030)
TABLE 21 HONG KONG FOAM DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2014-2019)
TABLE 22 HONG KONG FOAM DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2020-2030)
TABLE 23 HONG KONG FOAM DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2014-2019)
TABLE 24 HONG KONG FOAM DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2020-2030)
TABLE 25 HONG KONG HYDROCOLLOID DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2014-2019)
TABLE 26 HONG KONG HYDROCOLLOID DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2020-2030)
TABLE 27 HONG KONG HYDROCOLLOID DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2014-2019)
TABLE 28 HONG KONG HYDROCOLLOID DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2020-2030)
TABLE 29 HONG KONG FILM DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2014-2019)
TABLE 30 HONG KONG FILM DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2020-2030)
TABLE 31 HONG KONG FILM DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2014-2019)
TABLE 32 HONG KONG FILM DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2020-2030)
TABLE 33 HONG KONG ALGINATE DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2014-2019)
TABLE 34 HONG KONG ALGINATE DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2020-2030)
TABLE 35 HONG KONG ALGINATE DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2014-2019)
TABLE 36 HONG KONG ALGINATE DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2020-2030)
TABLE 37 HONG KONG ANTIMICROBIAL DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2014-2019)
TABLE 38 HONG KONG ANTIMICROBIAL DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2020-2030)
TABLE 39 HONG KONG ANTIMICROBIAL DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2014-2019)
TABLE 40 HONG KONG ANTIMICROBIAL DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2020-2030)
TABLE 41 HONG KONG HYDROGEL DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2014-2019)
TABLE 42 HONG KONG HYDROGEL DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2020-2030)
TABLE 43 HONG KONG HYDROGEL DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2014-2019)
TABLE 44 HONG KONG HYDROGEL DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2020-2030)
TABLE 45 HONG KONG COLLAGEN DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2014-2019)
TABLE 46 HONG KONG COLLAGEN DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2020-2030)
TABLE 47 HONG KONG COLLAGEN DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2014-2019)
TABLE 48 HONG KONG COLLAGEN DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2020-2030)
TABLE 49 HONG KONG HYDROFIBER DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2014-2019)
TABLE 50 HONG KONG HYDROFIBER DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2020-2030)
TABLE 51 HONG KONG HYDROFIBER DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2014-2019)
TABLE 52 HONG KONG HYDROFIBER DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2020-2030)
TABLE 53 HONG KONG WOUND CONTACT LAYER DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2014-2019)
TABLE 54 HONG KONG WOUND CONTACT LAYER DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2020-2030)
TABLE 55 HONG KONG WOUND CONTACT LAYER DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2014-2019)
TABLE 56 HONG KONG WOUND CONTACT LAYER DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2020-2030)
TABLE 57 HONG KONG SUPERABSORBENT DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2014-2019)
TABLE 58 HONG KONG SUPERABSORBENT DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2020-2030)
TABLE 59 HONG KONG SUPERABSORBENT DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2014-2019)
TABLE 60 HONG KONG SUPERABSORBENT DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2020-2030)
TABLE 61 HONG KONG WOUND CARE BIOLOGICS MARKET, BY TYPE, $’000 (2014-2019)
TABLE 62 HONG KONG WOUND CARE BIOLOGICS MARKET, BY TYPE, $’000 (2020-2030)
TABLE 63 HONG KONG SKIN SUBSTITUTES MARKET, BY TYPE, $’000 (2014-2019)
TABLE 64 HONG KONG SKIN SUBSTITUTES MARKET, BY TYPE, $’000 (2020-2030)
TABLE 65 HONG KONG WOUND THERAPY DEVICES MARKET, BY TYPE, $’000 (2014-2019)
TABLE 66 HONG KONG WOUND THERAPY DEVICES MARKET, BY TYPE, $’000 (2020-2030)
TABLE 67 HONG KONG TRADITIONAL WOUND DRESSING MARKET, BY TYPE, $’000 (2014-2019)
TABLE 68 HONG KONG TRADITIONAL WOUND DRESSING MARKET, BY TYPE, $’000 (2020-2030)
TABLE 69 HONG KONG TRADITIONAL WOUND DRESSING MARKET, BY TYPE, UNITS (2014-2019)
TABLE 70 HONG KONG TRADITIONAL WOUND DRESSING MARKET, BY TYPE, UNITS (2020-2030)
TABLE 71 HONG KONG WOUND DRESSING MARKET, BY APPLICATION, $’000 (2014-2019)
TABLE 72 HONG KONG WOUND DRESSING MARKET, BY APPLICATION, $’000 (2020-2030)
TABLE 73 HONG KONG WOUND DRESSING MARKET FOR CHRONIC WOUNDS, BY TYPE, $’000 (2014-2019)
TABLE 74 HONG KONG WOUND DRESSING MARKET FOR CHRONIC WOUNDS, BY TYPE, $’000 (2020-2030)
TABLE 75 HONG KONG WOUND DRESSING MARKET FOR ACUTE WOUNDS, BY TYPE, $’000 (2014-2019)
TABLE 76 HONG KONG WOUND DRESSING MARKET FOR ACUTE WOUNDS, BY TYPE, $’000 (2020-2030)
TABLE 77 HONG KONG WOUND DRESSING MARKET, BY END USER, $’000 (2014-2019)
TABLE 78 HONG KONG WOUND DRESSING MARKET, BY END USER, $’000 (2020-2030)
TABLE 79 HONG KONG WOUND DRESSING MARKET IN HOSPITALS AND SPECIALTY CLINICS, BY TYPE, $’000 (2014-2019)
TABLE 80 HONG KONG WOUND DRESSING MARKET IN HOSPITALS AND SPECIALTY CLINICS, BY TYPE, $’000 (2020-2030)
TABLE 81 HONG KONG WOUND DRESSING MARKET, BY DISTRIBUTION CHANNEL, $’000 (2014-2019)
TABLE 82 HONG KONG WOUND DRESSING MARKET, BY DISTRIBUTION CHANNEL, $’000 (2020-2030)
TABLE 83 3M COMPANY - SHARE BY PRODUCT
TABLE 84 CONVATEC GROUP PLC - SHARE BY PRODUCT
TABLE 85 COLOPLAST A/S - SHARE BY PRODUCT
TABLE 86 PAUL HARTMANN ASIA-PACIFIC LTD. - SHARE BY PRODUCT
TABLE 87 WINNER MEDICAL CO. LTD. - SHARE BY PRODUCT
TABLE 88 MÖLNLYCKE HEALTH CARE AB - SHARE BY PRODUCT
TABLE 89 SMITH & NEPHEW PLC - SHARE BY PRODUCT
TABLE 90 TUEN MUM HOSPITAL - SHARE BY PRODUCT
TABLE 91 UNITED CHRISTIAN HOSPITAL - SHARE BY PRODUCT
TABLE 92 QUEEN ELIZABETH HOSPITAL - SHARE BY PRODUCT
TABLE 93 PRINCE OF WALES HOSPITAL - SHARE BY PRODUCT
TABLE 94 PAMELA YOUNDE NETHERSOLE EASTERN HOSPITAL - SHARE BY PRODUCT
TABLE 95 PRINCESS MARGARET HOSPITAL - SHARE BY PRODUCT
TABLE 96 QUEEN MARY HOSPITAL - SHARE BY PRODUCT
TABLE 97 EVANGEL HOSPITAL - SHARE BY PRODUCT
TABLE 98 GLENEAGLES HONG KONG HOSPITAL - SHARE BY PRODUCT
TABLE 99 HONG KONG ADVENTIST HOSPITAL - SHARE BY PRODUCT
TABLE 100 HONG KONG BAPTIST HOSPITAL - SHARE BY PRODUCT
TABLE 101 HONH KONG SANATORIUM & HOSPITAL LIMITED - SHARE BY PRODUCT
TABLE 102 MATILDA & WAR MEMORIAL HOSPITAL - SHARE BY PRODUCT
TABLE 103 PRECIOUS BLOOD HOSPITAL - SHARE BY PRODUCT
TABLE 104 ST. PAUL’S HOSPITAL - SHARE BY PRODUCT
TABLE 105 ST. TERESA’S HOSPITAL - SHARE BY PRODUCT
TABLE 106 UNION HOSPITAL - SHARE BY PRODUCT
TABLE 107 CANOSSA HOSPITAL - SHARE BY PRODUCT
TABLE 108 COLOPLAST A/S - AT A GLANCE
TABLE 109 COLOPLAST A/S - KEY FINANCIAL SUMMARY
TABLE 110 3M COMPANY - AT A GLANCE
TABLE 111 3M COMPANY - KEY FINANCIAL SUMMARY
TABLE 112 PAUL HARTMANN AG - AT A GLANCE
TABLE 113 PAUL HARTMANN AG - KEY FINANCIAL SUMMARY
TABLE 114 WINNER MEDICAL CO. LTD. - AT A GLANCE
TABLE 115 MÖLNLYCKE HEALTH CARE AB - AT A GLANCE
TABLE 116 MÖLNLYCKE HEALTH CARE AB - KEY FINANCIAL SUMMARY
TABLE 117 SMITH & NEPHEW PLC - AT A GLANCE
TABLE 118 SMITH & NEPHEW PLC - KEY FINANCIAL SUMMARY
TABLE 119 CONVATEC GROUP PLC - AT A GLANCE
TABLE 120 CONVATEC GROUP PLC - KEY FINANCIAL SUMMARY
TABLE 121 ALLMED MEDICAL PRODUCTS CO. LTD. - AT A GLANCE
TABLE 122 ZHENDE MEDICAL CO. LTD. - AT A GLANCE
TABLE 123 WAYSON MEDICAL CO. LTD. - AT A GLANCE
TABLE 124 B. BRAUN MELSUNGEN AG - AT A GLANCE
TABLE 125 B. BRAUN MELSUNGEN AG - KEY FINANCIAL SUMMARY
TABLE 126 BSN MEDICAL GMBH - AT A GLANCE
TABLE 127 BEIERSDORF AG - AT A GLANCE
TABLE 128 BEIERSDORF AG - KEY FINANCIAL SUMMARY
TABLE 129 JOHNSON & JOHNSON - AT A GLANCE
TABLE 130 JOHNSON & JOHNSON - KEY FINANCIAL SUMMARY
TABLE 131 URGO MEDICAL - AT A GLANCE
TABLE 132 CARDINAL HEALTH INC. - AT A GLANCE
TABLE 133 CARDINAL HEALTH INC. - KEY FINANCIAL SUMMARY
TABLE 134 MEDTRONIC PLC - AT A GLANCE
TABLE 135 MEDTRONIC PLC - KEY FINANCIAL SUMMARY
TABLE 136 INTEGRA LIFESCIENCES HOLDINGS CORPORATION - AT A GLANCE
TABLE 137 INTEGRA LIFESCIENCES HOLDINGS CORPORATION - KEY FINANCIAL SUMMARY
TABLE 138 WRIGHT MEDICAL GROUP N.V. - AT A GLANCE
TABLE 139 WRIGHT MEDICAL GROUP N.V. - KEY FINANCIAL SUMMARY
TABLE 140 MEDELA HEALTHCARE - AT A GLANCE
TABLE 141 LOHMANN & RAUSCHER GMBH & CO. KG - AT A GLANCE
TABLE 142 NITTO DENKO CORPORATION - AT A GLANCE
TABLE 143 NITTO DENKO CORPORATION - KEY FINANCIAL SUMMARY
TABLE 144 WEIGAO GROUP CO. LTD. - AT A GLANCE
TABLE 145 WEIGAO GROUP CO., LTD. - KEY FINANCIAL SUMMARY

List of Figures
FIG 1 RESEARCH SCOPE
FIG 2 RESEARCH METHODOLOGY
FIG 3 SPLIT OF PRIMARY AND SECONDARY RESEARCH
FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY INDUSTRY PARTICIPANT
FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE
FIG 6 DATA TRIANGULATION APPROACH
FIG 7 HONG KONG WOUND CARE MARKET SUMMARY
FIG 8 BARGAINING POWER OF BUYERS
FIG 9 BARGAINING POWER OF SUPPLIERS
FIG 10 INTENSITY OF RIVALRY
FIG 11 THREAT OF NEW ENTRANTS
FIG 12 THREAT OF SUBSTITUTES
FIG 13 TOTAL INCIDENCE OF WOUNDS IN HONG KONG (2014-2030)
FIG 14 TYPE-SPECIFIC INCIDENCE OF WOUNDS IN HONG KONG (2014-2030)
FIG 15 INCIDENT CASES OF ACUTE WOUNDS, BY SYBTYPE IN HONG KONG (2014-2030)
FIG 16 INCIDENT CASES OF CHRONIC WOUNDS, BY SYBTYPE IN HONG KONG (2014-2030)
FIG 17 HONG KONG WOUND CARE MARKET SNAPSHOT
FIG 18 HONG KONG WOUND CARE MARKET, BY TYPE, $’000 (2014-2030)
FIG 19 HONG KONG ADVANCED WOUND CARE MARKET, BY TYPE, $’000 (2014-2030)
FIG 20 HONG KONG ADVANCED WOUND DRESSING MARKET, BY TYPE, $’000 (2014-2030)
FIG 21 HONG KONG TRADITIONAL WOUND DRESSING MARKET, BY TYPE, $’000 (2014-2030)
FIG 22 HONG KONG WOUND DRESSING MARKET, BY APPLICATION, $’000 (2014-2030)
FIG 23 HONG KONG WOUND DRESSING MARKET FOR CHRONIC WOUNDS, BY TYPE, $’000 (2014-2030)
FIG 24 HONG KONG WOUND DRESSING MARKET FOR ACUTE WOUNDS, BY TYPE, $’000 (2014-2030)
FIG 25 HONG KONG WOUND DRESSING MARKET, BY END USER, $’000 (2014-2030)
FIG 26 HONG KONG WOUND DRESSING MARKET IN HOSPITALS AND SPECIALTY CLINICS, BY TYPE, $’000 (2014-2030)
FIG 27 HONG KONG WOUND DRESSING MARKET, BY DISTRIBUTION CHANNEL, $’000 (2014-2030)
FIG 28 COMPETITIVE BENCHMARKING OF KEY PLAYERS BASED ON THEIR OFFERINGS
FIG 29 COLOPLAST A/S - REVENUE SPLIT BY BUSINESS AREA AND GEOGRAPHY (2019)
FIG 30 3M COMPANY - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 31 PAUL HARTMANN AG - REVENUE SPLIT BY BUSINESS DIVISION AND GEOGRAPHY (2019)
FIG 32 MÖLNLYCKE HEALTH CARE AB - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 33 SMITH & NEPHEW PLC - REVENUE SPLIT BY PRODUCT FRANCHISE AND GEOGRAPHY (2019)
FIG 34 CONVATEC GROUP PLC - REVENUE SPLIT BY FRANCHISE AND GEOGRAPHY (2019)
FIG 35 B. BRAUN MELSUNGEN AG - REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2019)
FIG 36 BEIERSDORF AG - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 37 JOHNSON & JOHNSON - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 38 CARDINAL HEALTH INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 39 MEDTRONIC PLC - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 40 INTEGRA LIFESCIENCES HOLDINGS CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 41 WRIGHT MEDICAL GROUP N.V. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 42 NITTO DENKO CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 43 WEIGAO GROUP CO., LTD. - REVENUE SPLIT BY PRINCIPLE PRODUCT AND GEOGRAPHY (2019)
Note: Product cover images may vary from those shown
  • Coloplast A/S
  • 3M Company
  • Paul Hartmann AG
  • Winner Medical Co. Ltd.
  • Mölnlycke Health Care AB
  • Smith & Nephew plc
  • ConvaTec Group PLC
  • Allmed Medical Products Co. Ltd.
  • Zhende Medical Co. Ltd.
  • Wayson Medical Co. Ltd.
  • B. Braun Melsungen AG
  • BSN medical GmbH
  • Beiersdorf AG
  • Johnson & Johnson
  • Urgo Medical
  • Cardinal Health Inc.
  • Medtronic plc
  • Integra LifeSciences Holdings Corporation
  • Wright Medical Group N.V.
  • Medela Healthcare
  • Lohmann & Rauscher GmbH & Co. KG
  • Nitto Denko Corporation
  • Weigao Group Co. Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll